World News | US Vaccinates 'several Hundred' People in First Days of Phase 3 COVID-19 Trials

Washington D.C. [US], July 31 (Sputnik/ANI): The United States vaccinated several hundred volunteers during the first days of two Phase 3 COVID-19 vaccine trials, senior administration official told reporters.

"Without revealing a lot of numbers, there were several hundred folks who get vaccinated on day one and the last couples of days," the official said on Thursday.

Also Read | China Facing Backlash, Our 'Quad Reinvigorated', Says Mike Pompeo Citing Diplomatic Moves by India, Japan.

Both trials began on Monday by Moderna and Pfizer companies in cooperation with the National Institutes of Health (NIH) and other federal health organizations, he added.

US government and private companies are building technologies for monitoring COVID-19 vaccine deployment, the official noted.

Also Read | Herman Cain, Ex-US Presidential Candidate and Former CEO of Godfather's Pizza, Dies Due to COVID-19.

"This is an extremely dynamic and unpredictable situation. We do not know how well these vaccines are going to work until we finish our clinical trials process," he said.

On July 27, the NIH said that US scientists have begun a phase three trial of a potential COVID-19 vaccine, known as mRNA-1273, developed by Moderna. NIH revealed plans to conduct the trial at multiple US clinical research sites with participation of approximately 30,000 adult volunteers who do not have COVID-19. (Sputnik/ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)